Gastric sleeve and kidney stones are more closely linked than many patients realise. Sleeve gastrectomy — one of the most commonly performed bariatric procedures in the UK — brings significant metabolic benefits, but also introduces physiological changes that can raise the risk of kidney stone formation. Reduced fluid intake, altered urinary chemistry, and changes in calcium and oxalate metabolism all play a role. Understanding these risks, recognising early symptoms, and taking targeted preventive steps are essential parts of long-term post-operative care for anyone who has undergone a sleeve gastrectomy.

Why Gastric Sleeve Surgery Increases Kidney Stone Risk

Sleeve gastrectomy raises kidney stone risk mainly through reduced fluid intake causing concentrated urine, hypocitraturia, lower urinary pH, and altered calcium metabolism — not intestinal malabsorption.

Have any more questions about this? Message our pharmaceutical team to get more info →

Gastric sleeve surgery, formally known as sleeve gastrectomy, is one of the most commonly performed bariatric procedures in the UK. While it offers significant benefits for weight loss and metabolic health, it also introduces physiological changes that can increase the risk of developing kidney stones. Understanding why this happens is an important part of long-term post-operative care.

Following a sleeve gastrectomy, the stomach is reduced to roughly 15–20% of its original size. This restriction leads to reduced food and fluid intake, which can make it difficult to maintain adequate hydration. If fluid intake is consistently insufficient, urine becomes concentrated — one of the primary drivers of kidney stone formation, as minerals such as calcium oxalate, uric acid, and calcium phosphate are more likely to crystallise when urine volume is low.

Sleeve gastrectomy is a predominantly restrictive procedure and does not involve rerouting the intestine. As a result, the principal metabolic risk factors for kidney stones after sleeve gastrectomy differ somewhat from those seen after Roux-en-Y gastric bypass (RYGB). The main drivers after sleeve gastrectomy include:

• Low urine volume due to reduced fluid intake

• Hypocitraturia — reduced urinary citrate, a natural inhibitor of stone formation

• Lower urinary pH, which promotes uric acid stone formation

• Altered calcium metabolism associated with rapid weight loss

Hyperixaluria (raised urinary oxalate) is a recognised risk after bariatric surgery but is considerably more pronounced after RYGB, which involves intestinal bypass and fat malabsorption, than after sleeve gastrectomy. Overall, the risk of kidney stones after sleeve gastrectomy is lower than after RYGB, but it remains clinically significant and warrants ongoing attention throughout post-operative care.

How Oxalate Absorption Changes After Weight Loss Surgery

Enteric hyperoxaluria is primarily a risk after Roux-en-Y gastric bypass; sleeve gastrectomy patients can still develop mildly raised urinary oxalate if dietary calcium intake is insufficient.

One mechanism linking bariatric surgery and kidney stones involves changes in how the body handles oxalate — a naturally occurring compound found in many foods. Under normal circumstances, oxalate in the gut binds to calcium to form an insoluble compound that is excreted in the stool. After certain types of bariatric surgery, this process can be disrupted.

This disruption — known as enteric hyperoxaluria — is primarily associated with malabsorptive procedures such as Roux-en-Y gastric bypass. In RYGB, fat malabsorption means that free fatty acids bind to calcium in the gut, leaving less calcium available to bind oxalate. The unbound oxalate is then absorbed into the bloodstream and excreted by the kidneys in greater quantities, raising the risk of calcium oxalate stones.

After sleeve gastrectomy, fat malabsorption is not a typical feature, as the small intestine remains intact. However, sleeve patients can still develop mildly elevated urinary oxalate if their dietary calcium intake is inadequate or if they consume a high-oxalate diet. Ensuring sufficient dietary calcium — consumed with meals so that it is available to bind oxalate in the gut — is therefore an important preventive measure.

Foods particularly high in oxalate include:

• Spinach, beetroot, and Swiss chard

• Nuts, particularly almonds and cashews

• Chocolate and cocoa

• Tea (especially black tea) — moderate consumption alongside calcium-containing foods is preferable to complete avoidance

• Rhubarb

For most sleeve gastrectomy patients, the priority is ensuring adequate calcium intake with meals rather than severely restricting oxalate-containing foods, which can compromise overall nutritional balance. Dietary counselling from a registered dietitian experienced in bariatric nutrition is an important component of post-operative care.

Recognising Symptoms of Kidney Stones Post-Surgery

The hallmark symptom is renal colic — severe flank pain radiating to the groin — but fever combined with urinary symptoms signals a potential emergency requiring immediate hospital assessment.

Kidney stones can range from entirely asymptomatic — discovered incidentally on imaging — to acutely painful and potentially serious. After gastric sleeve surgery, patients should be familiar with the warning signs so that they can seek timely medical attention.

The hallmark symptom of a kidney stone is renal colic: a severe, cramping pain that typically begins in the flank (the side of the back, below the ribs) and may radiate to the lower abdomen, groin, or inner thigh. This pain often comes in waves and can be debilitating. It occurs when a stone moves from the kidney into the ureter, causing obstruction and spasm.

Other symptoms to be aware of include:

• Haematuria — blood in the urine, which may appear pink, red, or brown; in some cases it is microscopic and detected only on urine dipstick testing

• Dysuria — pain or burning during urination

• Urinary frequency or urgency

• Nausea and vomiting, which may be mistaken for post-operative digestive symptoms

• Cloudy or foul-smelling urine, which may suggest an associated urinary tract infection (UTI)

• Fever and chills — a potential sign of infection, requiring urgent assessment

It is worth noting that some post-bariatric patients may attribute early symptoms such as nausea or flank discomfort to their surgery or dietary changes, potentially delaying diagnosis. A high index of suspicion is therefore warranted, particularly in patients who are not maintaining adequate fluid intake or who have a prior history of kidney stones.

Fever combined with flank pain and urinary symptoms should be treated as a medical emergency. This combination may indicate an infected obstructed kidney (pyonephrosis), which carries a risk of sepsis and requires urgent hospital assessment, decompression, and intravenous antibiotics.

Diagnosis and NHS Treatment Options for Kidney Stones

NICE NG118 recommends CT KUB within 24 hours for suspected renal colic; treatment ranges from hydration and analgesia for small stones to ureteroscopy or PCNL for larger ones.

If kidney stones are suspected, a GP will typically arrange initial investigations before referring to secondary care if necessary. NICE guideline NG118 (Renal and ureteric stones: assessment and management) provides the framework for assessment and management of kidney stones in adults in England.

Investigations commonly used include:

• Urine dipstick and microscopy — to detect haematuria (including microscopic), infection, or crystals

• Non-contrast CT of the kidneys, ureters, and bladder (CT KUB) — the gold-standard imaging modality; NICE NG118 recommends this is performed within 24 hours for adults presenting with suspected renal colic

• Ultrasound — used as a first-line imaging tool in pregnancy or where minimising radiation exposure is a priority

• Blood tests — including renal function (eGFR, creatinine), serum calcium, urate, and bicarbonate

• 24-hour urine collection — recommended for recurrent stone formers to assess urinary oxalate, calcium, citrate, urate, and volume

• Stone analysis — NICE NG118 recommends offering stone analysis on first presentation where a stone is passed or retrieved, to guide preventive management

Treatment depends on the size and location of the stone, as well as the patient's symptoms and overall health. Many small stones (under 5 mm) pass spontaneously with adequate hydration and analgesia. NSAIDs such as diclofenac are commonly used as first-line analgesia for renal colic; however, post-bariatric patients should be aware that NSAIDs carry an increased risk of gastrointestinal ulceration, and prescribers may recommend concurrent gastroprotection (such as a proton pump inhibitor) or consider alternative analgesics where NSAIDs are contraindicated. Renal function and cardiovascular risk should also be taken into account.

For selected patients with distal ureteric stones smaller than 10 mm who are not undergoing immediate intervention, NICE NG118 recommends considering an alpha-blocker (such as tamsulosin) to facilitate stone passage — this is an off-label use and should be discussed with a clinician.

For larger or obstructing stones, NHS treatment options include:

• Extracorporeal shockwave lithotripsy (ESWL) — uses sound waves to break up stones

• Ureteroscopy with laser lithotripsy — a minimally invasive endoscopic procedure

• Percutaneous nephrolithotomy (PCNL) — for larger or complex stones

An infected obstructed kidney is a urological emergency requiring urgent decompression (via ureteric stent or nephrostomy) alongside intravenous antibiotics. Patients with recurrent stones following bariatric surgery may benefit from referral to a specialist metabolic stone clinic for tailored preventive management.

Dietary and Lifestyle Steps to Reduce Your Risk

Aiming for 2–2.5 litres of urine output daily is the single most important preventive measure, alongside adequate dietary calcium at mealtimes and limiting sodium and animal protein.

Prevention is central to managing kidney stone risk after gastric sleeve surgery. A combination of dietary modifications, adequate hydration, and targeted supplementation can significantly reduce the likelihood of stone formation.

Hydration is the single most important preventive measure. Guidance from BAUS (British Association of Urological Surgeons) and the EAU (European Association of Urology) recommends aiming for a urine output of at least 2–2.5 litres per day, which typically requires a fluid intake of around 2.5–3 litres daily depending on activity and climate. Given the reduced stomach capacity after sleeve gastrectomy, achieving this requires consistent, small sips of water throughout the day rather than large volumes at once. Plain water is preferable; diluted lemon juice or other citrus-based drinks may also help by increasing urinary citrate levels. Patients with heart failure, chronic kidney disease, or other conditions affecting fluid balance should seek personalised advice from their clinical team before significantly increasing fluid intake.

Dietary calcium intake should not be restricted. A common misconception is that reducing calcium intake will lower stone risk. In fact, adequate dietary calcium — consumed with meals — helps bind oxalate in the gut, reducing its absorption into the bloodstream. Where calcium supplements are required post-bariatric surgery, calcium citrate is generally preferred over calcium carbonate, as it is better absorbed in the altered gastric environment and also provides citrate, which itself inhibits stone formation. Calcium supplements should always be taken with food.

Other evidence-based dietary recommendations include:

• Moderate oxalate intake — reduce high-oxalate foods if hyperoxaluria has been confirmed, but avoid unnecessary restriction that could compromise nutrition

• Limit sodium — a high salt intake increases urinary calcium excretion; aim for no more than 5–6 g of salt per day

• Moderate animal protein — excess protein raises urinary uric acid and calcium, and lowers citrate

• Avoid vitamin C megadosing — high-dose vitamin C supplements (generally above 1,000 mg per day) can be metabolised to oxalate and should be avoided

• Limit cola-type drinks — these contain phosphoric acid, which may adversely affect urinary chemistry

• Maintain a healthy weight — obesity itself is a risk factor for uric acid stones

Post-bariatric patients should work closely with a registered dietitian experienced in bariatric nutrition to ensure their dietary plan balances stone prevention with the nutritional demands of recovery and long-term health. The British Dietetic Association (BDA) and NHS provide further patient-facing dietary guidance on kidney stone prevention.

When to Seek Medical Advice After Gastric Sleeve Surgery

Contact your GP promptly for unexplained flank pain or blood in the urine; call 999 or go to A&E immediately if fever, severe uncontrolled pain, or signs of sepsis are present.

Knowing when to contact a GP or seek urgent care is an essential part of safe recovery following gastric sleeve surgery. Because some kidney stone symptoms can overlap with post-operative digestive complaints, patients should err on the side of caution and seek assessment if they are uncertain.

Contact your GP promptly if you experience:

• Persistent or recurrent flank or lower abdominal pain not explained by your surgery

• Blood in the urine, even if painless

• Burning or pain on urination

• Recurrent urinary tract infections

• Nausea or vomiting that seems unrelated to eating

If you are unsure whether your symptoms need urgent attention, call NHS 111 for advice at any time of day or night.

Seek urgent or emergency care (call 999 or go to A&E) if you have:

• Severe, uncontrolled pain

• Fever (temperature above 38°C) alongside urinary symptoms or flank pain

• Inability to pass urine

• Signs of sepsis, including confusion, rapid breathing, or extreme fatigue

Patients who have already had one kidney stone after bariatric surgery are at significantly increased risk of recurrence and should discuss this with their GP or bariatric team. A referral to urology or a metabolic stone clinic may be appropriate for ongoing monitoring and preventive treatment. Preventive medicines — such as potassium citrate, allopurinol, or thiazide diuretics — may be considered by a specialist following stone analysis and metabolic workup, as the choice of medication depends on the stone type and individual urinary chemistry.

Regular follow-up with the bariatric multidisciplinary team — including dietetic support, blood and urine monitoring, and hydration counselling — remains the cornerstone of long-term care. Patients are encouraged to raise any concerns about kidney stone symptoms at their routine post-operative appointments, as early intervention can prevent more serious complications.

Frequently Asked Questions